VP of clinical pharmacology at Tesaro

Ensure best practice clinical pharmacology and PK/PD principles are applied through due diligence reviews. Then for aquired assets, provide strategic input and direct oversight of all clinical pharmacology activities needed to support the BP portfolio. Leverage external expertise to ensure appropriate coverage to the clinical programs.

Global Head of Clinical Pharmacology; responsible for clinical pharmacology activities at sites in Cambridge, MA, Deerfeild IL, Japan and London, UK

Senior Director, Clinical Pharmacology, head of departmentMillennium now formed into the Takeda, Oncology TAU based In Boston, US. Head of Clinical Pharmacology Dept. in support of all Oncology developement at TakedaOversee 17 clinical pharmacologists in support of early and late stage development teamsGlobal development oversight with direct reports in JapanProvide strategic drug development and expert clin pharm guidance to my senior direct reportsStanding member of the oncology develpement governace committees and project review boardMangage department budget for software tools, external contracts for expert services, expenses and training.

Was Microbia, changed its name to Ironwood Pharmaceuticals, just a re brandingProvided the only clinical pharmacology resouce for the company and partnered closely with clinical and non clinical DMPK to drive the clin pharm strategy for Linacolotide (Linzess) and saw this to final NDA stage. Now an approved drug.Engaged the FDA during the CTD review stage in person during milestone development meeting and in writing responding to clinical pharmacology questions and comments.Provided input and guidance for other early deveopment programs in the areas of pain and CVmed and assited in due dillagence activities.